Print Page     Close Window     

SEC Filings

20-F
AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document
 

 

 

ARTICLE 8 INTELLECTUAL PROPERTY 45
     
  8.1 Ownership of Intellectual Property. 45
  8.2 Maintenance and Prosecution of Patents. 47
  8.3 Enforcement of Patents. 49
  8.4 Infringement Claims by Third Parties. 51
  8.5 Invalidity or Unenforceability Defenses or Actions. 51
  8.6 Third Party Rights. 52
  8.7 Product Trademarks. 52
  8.8 ACI’s Corporate Names. 53
     
ARTICLE 9 CONFIDENTIALITY AND NON-DISCLOSURE 53
     
  9.1 Confidentiality Obligations 53
  9.2 Permitted Disclosures 55
  9.3 Additional Permitted Disclosures by Lilly 55
  9.4 Additional Permitted Disclosures by ACI 55
  9.5 Use of Name 55
  9.6 Public Announcements 56
  9.7 Publications 56
  9.8 Return of Confidential Information. 57
     
ARTICLE 10 REPRESENTATIONS AND WARRANTIES 57
     
  10.1 Mutual Representations and Warranties 57
  10.2 Additional Representations and Warranties of ACI 58
  10.3 DISCLAIMER OF WARRANTIES. 61
  10.4 Anti-Bribery and Anti-Corruption Compliance 61
     
ARTICLE 11 INDEMNITY 62
     
  11.1 Indemnification of ACI. 62
  11.2 Indemnification of Lilly. 62
  11.3 Indemnification Procedures. 63
  11.4 Special, Indirect and Other Losses 65
  11.5 Insurance. 65
     

 

 ii


© AC Immune 2015